Redox Point-of-Care Platform

Sensor technology that utilizes nanoporous gold electrodes integrated into a microfluidic device, to directly measure redox in whole blood at the patient’s bedside. The ability to directly and rapidly measure redox could help guide therapeutic interventions in a variety of patients.

By providing information to clinicians related to responsive drug delivery and responsiveness to resuscitation efforts, the Redox Point-of-Care Device can improve outcomes and reduce costs in TBI, Sepsis and other diseases

View Project Sheet

Rodney Daniels, MD (PI)
Hakam Tiba, MD, MS (Co-I)
Brendan McCracken, MS

Acute Kidney Injury

(Currently in Development)